Roivant Sciences, a pioneering biopharmaceutical company headquartered in the United States, focuses on advancing innovative therapies to address unmet medical needs. Founded in 2014, Roivant has rapidly established itself within the biotechnology industry, particularly in the fields of drug development and commercialisation. The company is renowned for its unique approach to drug development, leveraging its extensive portfolio of subsidiaries, known as "Vants," which specialise in various therapeutic areas. Roivant's commitment to utilising technology and data analytics distinguishes it from traditional pharmaceutical companies, enabling faster and more efficient pathways to market. With a strong market position, Roivant has achieved significant milestones, including successful partnerships and the launch of several promising therapies. Its dedication to transforming healthcare continues to drive its growth and influence in the biopharmaceutical landscape.
How does Roivant Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Roivant Sciences's score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Roivant Sciences, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the biopharmaceutical sector are increasingly focusing on sustainability and climate commitments. Roivant Sciences may be expected to align with industry standards and practices in addressing climate change, but specific initiatives or targets have not been disclosed at this time.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roivant Sciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.